查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606438

微针流感疫苗市场，按产品类型、按疫苗类型、按应用、按国家和地区 - 2024-2032 年行业分析、市场应用、市场份额和预测

Microneedle Flu Vaccine Market, By Product Type, By Vaccine Type, By Application, By Country, and By Region - Industry Analysis, Market Application, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年微针流感疫苗市场应用价值为16.3043亿美元，2024年至2032年复合年增长率为6.30%。

微针流感疫苗市场-市场动态

对加强疫苗输送和无针注射的需求不断增加预计将推动市场需求

微针流感疫苗透过皮内注射增强免疫反应。对更有效和对患者友好的疫苗技术的兴趣增加。无针注射减少了与传统针疫苗相关的恐惧和焦虑，提高了患者的依从性，从而促进了市场成长。此外，人们越来越认识到流感对公共卫生的影响，也推动了疫苗的采用。 COVID-19 大流行凸显了对可扩展、可获取且高效的疫苗解决方案的需求，增加了人们对微针技术的兴趣。强调全民免疫的运动增加了创新输送系统的需求。

老年人口特别容易感染流感，需要更安全、更舒适的疫苗接种方法。此外，人们对家庭医疗保健解决方案的日益青睐与微针贴片的自我管理性质一致。它消除了锐器废物，减少了对环境的影响以及对专门处理系统的需求。降低医护人员被针刺伤的风险。此外，微针系统正用于某些应用，例如药物输送，广泛的商业用途正在促进市场成长。

微针流感疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.30% 左右的复合年增长率成长

根据产品类型细分，由于其在疫苗中的有效性，空心微针细分市场预计将在 2023 年显示最大的市场份额。

根据疫苗类型细分，由于在病毒株中的应用更广泛，四价流感疫苗细分市场将成为 2023 年领先的疫苗类型细分市场。

从应用细分来看，药物传输领域是2023年领先的应用领域，主要是由于其更容易获得和监管支持。

从地区来看，由于药物输送的研发投资不断增加，北美成为 2023 年的主要收入来源。

微针流感疫苗市场-細項分析：

全球微针流感疫苗市场根据产品类型、疫苗类型、应用和地区进行细分。

市场依产品类型分为两类：实心微针和空心微针。空心微针细分市场占据主导地位。疫苗输送的可靠性更高，推动了对空心微针的需求。

市场依疫苗类型分为两类：四价流感疫苗和三价流感疫苗。四价流感疫苗市场占主导地位。四价流感疫苗可针对甲型和乙型流感病毒株提供保护，增加了细分市场的需求。

市场依应用分为三类：研究与临床试验、药物传递等。预计药物传输领域在预测期内将以最快的速度成长。微针在药物传输方面的需求不断增长，因为它们在疫苗传输方面更加高效、可靠且用户友好，预计将推动该领域的成长。

微针流感疫苗市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。在北美，由于强劲的研发资金、生技公司的存在以及监管支持，美国在该市场占据主导地位。高认知度、先进的医疗基础设施以及对创新疫苗解决方案的需求。此外，微针技术的临床试验和 FDA 批准的投资也在增加。在欧洲，德国、法国和英国在采用创新疫苗技术方面处于领先地位。在亚太地区，中国、日本和印度显示出巨大的成长潜力。

微针流感疫苗市场-竞争格局：

微针流感疫苗市场性质温和，并随着製药业的发展而迅速发展。该市场是由无痛疫苗输送技术的创新所驱动的。微针技术因其增强疫苗可及性的潜力而得到越来越多的认可，特别是在偏远或资源有限的环境中。公司正在大力投资先进材料和设计，以提高效率并降低成本。多家公司已与世界卫生组织或盖兹基金会合作，在低收入国家分发。一些顶级企业正在亚太地区建立製造工厂，以满足不断增长的需求。

2023 年，Vaxxas 获得了 BARDA（生物医学高级研究与发展局）等机构的资助，用于推进和开发流感疫苗微针贴片。

2022 年 11 月，美光生物医学公司获得 1,400 万美元投资，用于支持其商业製造。

目录

第一章：微针流感疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的微针流感疫苗市场片段
    • 按疫苗类型分類的微针流感疫苗市场片段
    • 微针流感疫苗市场片段（依应用）
    • 微针流感疫苗市场片段（按国家/地区）
    • 按地区分類的微针流感疫苗市场片段
  • 竞争洞察

第 3 章：微针流感疫苗主要市场趋势

  • 微针流感疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 微针流感疫苗市场限制
    • 市场限制影响分析
  • 微针流感疫苗市场机会
  • 微针流感疫苗市场未来趋势

第 4 章：微针流感疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：微针流感疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：微针流感疫苗市场格局

  • 2023 年微针流感疫苗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：微针流感疫苗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 实心微针
    • 空心微针

第 8 章：微针流感疫苗市场 - 依疫苗类型

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 四价流感疫苗
    • 三价流感疫苗

第 9 章：微针流感疫苗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 研究与临床试验
    • 药物输送
    • 其他的

第 10 章：微针流感疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美微针流感疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按疫苗类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲微针流感疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按疫苗类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区微针流感疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依疫苗类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲微针流感疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按疫苗类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲微针流感疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按疫苗类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-微针流感疫苗产业

  • 竞争仪表板
  • 公司简介
    • 3M Drug Delivery Systems
    • Becton, Dickinson, and Company
    • Micron Biomedical Inc.
    • NanoPass Technologies
    • Vaxxas
    • Zosano Pharma Corporation
    • Corium, Inc.
    • TheraJect
    • Verndari, Inc.
    • Inovio Pharmaceuticals, Inc.
    • Xiamen Innovax Biotech Co., Ltd.
    • BioSerenTach
    • Transdermal Specialties, Inc.
    • EmulTech BV
    • Clearside Biomedical, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4221

REPORT HIGHLIGHT

Microneedle Flu Vaccine Market Application was valued at USD 1,630.43 Million in 2023, expanding at a CAGR of 6.30% from 2024 to 2032.

The microneedle flu vaccine is an innovative approach to delivering influenza vaccines using microneedles, which are tiny needles typically smaller than a millimeter embedded in a small patch or device. This technology is designed to make vaccination easier, less painful, and potentially more accessible compared to traditional syringe-based methods.

Microneedle Flu Vaccine Market- Market Dynamics

Increasing demand for enhanced vaccine delivery & needle-free administration is expected to propel market demand

Microneedle flu vaccination provides enhanced immune response through intradermal delivery. Increased interest in more effective and patient-friendly vaccine technologies. Needle-free administration reduces fear and anxiety associated with traditional needle-based vaccines, increasing patient compliance, thereby boosting market growth. Also, increasing recognition of influenza's public health impact drives vaccine adoption. The COVID-19 pandemic highlighted the need for scalable, accessible, and efficient vaccine solutions, increasing interest in microneedle technology. Campaigns emphasizing universal immunization boost demand for innovative delivery systems.

Older adult population, particularly vulnerable to influenza, requires safer and more comfortable vaccination methods. Further, the growing preference for home healthcare solutions aligns with the self-administered nature of microneedle patches. It eliminates sharps waste, reducing environmental impact and the need for specialized disposal systems. Lowers the risk of needle-stick injuries for healthcare workers. Furthermore, microneedle systems are being used for certain applications such as drug delivery, and widespread commercial use is contributing to market growth.

Microneedle Flu Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.30% over the forecast period (2024-2032)

Based on Product Type segmentation, the hollow microneedle segment was predicted to show maximum market share in 2023, owing to their effectiveness in vaccines.

Based on Vaccine Type segmentation, the quadrivalent flu vaccine segment was the leading Vaccine Type segment in 2023, due to wider applications in virus strains.

Based on application segmentation, the drug delivery segment was the leading application segment in 2023, mainly due to its greater accessibility and regulatory support.

On the basis of region, North America was the leading revenue generator in 2023, due to the increasing R&D investment in drug delivery.

Microneedle Flu Vaccine Market- Segmentation Analysis:

Global Microneedle Flu Vaccine Market is segmented on the basis of Product Type, Vaccine Type, Application, and Region.

The market is divided into two categories based on the Product Type: solid microneedle and hollow microneedle. The hollow microneedle segment dominates the market. The greater reliability in delivering the vaccine is boosting demand for hollow microneedle.

The market is divided into two categories based on Vaccine Type: quadrivalent flu vaccine and trivalent flu vaccine. The quadrivalent flu vaccine segment dominates the market. The quadrivalent flu vaccine provides protection against influenza A & B strains, increasing segment demand.

The market is divided into three categories based on Application: research & clinical trials, drug delivery, and others. The drug delivery segment is anticipated to grow at the fastest rate over the forecast period. The growing demand for microneedles in drug delivery as they are more efficient & reliable in vaccine deliverables & user-friendly is expected to fuel segment growth.

Microneedle Flu Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, the U.S. dominates this market due to robust R&D funding, presence of biotech firms, and regulatory support. High awareness, advanced healthcare infrastructure, and demand for innovative vaccine solutions. Also, there is increasing investment in clinical trials and FDA approvals for microneedle technology. In Europe, Germany, France, and the UK lead in adopting innovative vaccine technologies. In Asia Pacific region, China, Japan, and India show significant growth potential opportunities.

Microneedle Flu Vaccine Market- Competitive Landscape:

The Microneedle Flu Vaccine market is moderately in nature and is rapidly evolving with pharma industry. The market is driven by innovations in painless vaccine delivery technologies. Microneedle technology is being increasingly recognized for its potential to enhance vaccine accessibility, particularly in remote or resource-limited settings. Companies are heavily investing in advanced materials and designs for higher efficacy and lower costs. Several companies have partnered with WHO or Gates Foundation for distribution in low-income countries. Some of the top players are building manufacturing units in Asia-Pacific to meet growing demand.

In 2023, Vaxxas have received grants from agencies like BARDA (Biomedical Advanced Research and Development Authority) to advance & develop flu vaccine microneedle patches.

In November 2022, Micron Biomedical, Inc. received USD 14 million through their investment to bolster its commercial manufacturing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICRONEEDLE FLU VACCINE MARKET KEY PLAYERS

  • 3M Drug Delivery Systems
  • Becton, Dickinson, and Company
  • Micron Biomedical Inc.
  • NanoPass Technologies
  • Vaxxas
  • Zosano Pharma Corporation
  • Corium, Inc.
  • TheraJect
  • Verndari, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Xiamen Innovax Biotech Co., Ltd.
  • BioSerenTach
  • Transdermal Specialties, Inc.
  • EmulTech BV
  • Clearside Biomedical, Inc.
  • Others

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Solid microneedle
  • Hollow microneedle

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Quadrivalent flu vaccine
  • Trivalent flu vaccine

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Research & clinical trials
  • Drug delivery
  • Others

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Microneedle Flu Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Microneedle Flu Vaccine Market Snippet by Product Type
    • 2.1.2. Microneedle Flu Vaccine Market Snippet by Vaccine Type
    • 2.1.3. Microneedle Flu Vaccine Market Snippet by Application
    • 2.1.4. Microneedle Flu Vaccine Market Snippet by Country
    • 2.1.5. Microneedle Flu Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Microneedle Flu Vaccine Key Market Trends

  • 3.1. Microneedle Flu Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Microneedle Flu Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Microneedle Flu Vaccine Market Opportunities
  • 3.4. Microneedle Flu Vaccine Market Future Trends

4. Microneedle Flu Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Microneedle Flu Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Microneedle Flu Vaccine Market Landscape

  • 6.1. Microneedle Flu Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Microneedle Flu Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Solid microneedle
    • 7.1.3. Hollow microneedle

8. Microneedle Flu Vaccine Market - By Vaccine Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 8.1.2. Quadrivalent flu vaccine
    • 8.1.3. Trivalent flu vaccine

9. Microneedle Flu Vaccine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Research & clinical trials
    • 9.1.3. Drug delivery
    • 9.1.4. Others

10. Microneedle Flu Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Microneedle Flu Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Microneedle Flu Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Microneedle Flu Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Microneedle Flu Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Microneedle Flu Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Microneedle Flu Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 3M Drug Delivery Systems
    • 11.2.2. Becton, Dickinson, and Company
    • 11.2.3. Micron Biomedical Inc.
    • 11.2.4. NanoPass Technologies
    • 11.2.5. Vaxxas
    • 11.2.6. Zosano Pharma Corporation
    • 11.2.7. Corium, Inc.
    • 11.2.8. TheraJect
    • 11.2.9. Verndari, Inc.
    • 11.2.10. Inovio Pharmaceuticals, Inc.
    • 11.2.11. Xiamen Innovax Biotech Co., Ltd.
    • 11.2.12. BioSerenTach
    • 11.2.13. Transdermal Specialties, Inc.
    • 11.2.14. EmulTech BV
    • 11.2.15. Clearside Biomedical, Inc.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us